ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Validation of the Model for End-Stage Liver Disease Sodium Score in the Eurotransplant Region

B. F. Goudsmit1, H. Putter2, B. Van Hoek3, A. E. Braat1

1Transplantation Surgery, Leiden University Medical Center, Leiden, Netherlands, 2Biostatistics, Leiden University Medical Center, Leiden, Netherlands, 3Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, Netherlands

Meeting: 2020 American Transplant Congress

Abstract number: A-123

Keywords: Allocation, Liver transplantation, Waiting lists

Session Information

Session Name: Poster Session A: Liver: MELD, Allocation and Donor Issues (DCD/ECD)

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: The shortage of liver grafts results in the prioritization of the sickest patients on the waiting list for liver transplantation. Since 2006, the degree of disease severity in transplant candidates in the Eurotransplant (ET) region is estimated with the Model for End-stage Liver Disease (MELD) score. However, MELD does not account for the worse prognosis associated with hyponatremia. Since the prevalence of cirrhosis is on the rise, better prediction of mortality and improved allocation for liver transplantation are becoming increasingly important. This study researches the potential impact of using MELD-Na instead of MELD for the allocation of livers in the Eurotransplant region.

*Methods: All candidates allocated through MELD with chronic liver disease on the ET liver transplant waiting list between 2007-2018 were included. They were followed from first listing to delisting or until 90 days. The relation between MELD and Na values at listing and 90-day mortality was assessed through a multivariate Cox proportional hazard regression. A reclassification table was constructed of the relevant changes in MELD to MELD-Na score. This allowed an estimation of the lives saved if MELD-Na-based allocation would have been used.

*Results: 5223 patients were included. After 90 days, 21.3% were transplanted, 24.2% were removed and 2.8% had died. Hyponatremia of &lt135, &lt130 and &lt125 mmol/L was found in respectively 28.5%, 8.8% and 2.6% of the listed patients. Between 140 to 125 mmol/L, the MELD-corrected risk of 90-day death increased by threefold (2.9; 95%CI 2.30-3.53; p&lt0.001). The hazard ratio for death was 1.16 (95%CI 1.15-1.17; p&lt0.001) per gained MELD point and 1.08 (95%CI 1.06-1.09; p&lt0.001) per 1-unit Na decrease. The MELD-Na had a c-index of 0.847 (SE 0.007, p&lt0.001). Of the deceased patients, 26.3% would have had a significantly higher chance of transplantation with MELD-Na, which equals to an estimated 4.9% decrease in 90-day waiting list mortality.

*Conclusions: The ET waiting list population has a relatively high prevalence of hyponatremia. For transplant candidates, a low Na increases the risk of 90-day mortality by threefold. If MELD-Na would have been used, 26.3% of the deceased patients could have had a significantly higher chance of transplantation. The 90-day waiting list mortality in our study population could have been lowered by 4.9%. Thus, MELD-Na-based allocation could reduce waiting list mortality for the ET region.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Goudsmit BF, Putter H, Hoek BVan, Braat AE. Validation of the Model for End-Stage Liver Disease Sodium Score in the Eurotransplant Region [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/validation-of-the-model-for-end-stage-liver-disease-sodium-score-in-the-eurotransplant-region/. Accessed May 10, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences